Discounted Cash Flow Rating
Strong Sell
Return on Equity Rating
Strong Buy
Debt to Equity Rating
Strong Sell
Price to Earnings Rating
Strong Sell
Analyst Rating
Sell
Simple Moving Average
Buy
Exponential Moving Average
Buy
Relative Strength Index
Neutral
Standard Deviation
Sell
Williams %R
Strong Buy
Average Directional Index
Sell
Insider Trading
Neutral
Wall Street Data Solutions Rating
Neutral
B
NLS Pharmaceutics Ltd. Ordinary Shares (NLSP)
NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders. It focuses on developing therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company's tangible assets are held in the United States. Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.
Current Price
---.--
% Change Today
0.00%
Change Amt. Today
0.00
Active Status
Active
Listing Date
01/29/2021
Market Cap
8,240,686
Shares Outstanding
35,670,000
Weighted SO
35,671,780
Total Employees
N/A
Upcoming Earnings
N/A
Beta
-0.5310
Last Div
0.0000
Range
0.111-1.205
Chg
0.0054
Avg Vol
12327908
Mkt Cap
8240686
Exch
NASDAQ
Country
CH
Phone
41 44 512 21 50
DCF Diff
0.1905
DCF
-0.0193
Div Yield
0.0000
P/S
0.0000
EV Multiple
-0.7610
P/FV
-0.6483
Div Yield %
0.0000
P/E
-0.4705
PEG
-0.0076
Payout
0.0000
Current Ratio
0.2302
Quick Ratio
0.2302
Cash Ratio
0.1133
DSO
0.0000
DIO
0.0000
Op Cycle
0.0000
DPO
148250.3427
CCC
0.0000
Gross Margin
0.0000
Op Margin
0.0000
Pretax Margin
0.0000
Net Margin
0.0000
Eff Tax Rate
0.0000
ROA
-6.5914
ROE
1.8554
ROCE
1.9442
NI/EBT
1.0000
EBT/EBIT
1.0309
EBIT/Rev
0.0000
Debt Ratio
0.8847
D/E
-0.1849
LT Debt/Cap
0.0000
Total Debt/Cap
-0.2269
Int Coverage
-81.3422
CF/Debt
-5.9278
Equity Multi
-0.2090
Rec Turnover
0.0000
Pay Turnover
0.0025
Inv Turnover
0.0000
FA Turnover
0.0000
Asset Turnover
0.0000
OCF/Share
-0.2986
FCF/Share
-0.2986
Cash/Share
0.0277
OCF/Sales
0.0000
FCF/OCF
1.0000
CF Coverage
-5.9278
ST Coverage
-5.9278
CapEx Coverage
0.0000
Div&CapEx Cov
0.0000
P/BV
-0.6483
P/B
-0.6483
P/S
0.0000
P/E
-0.4705
P/FCF
-0.8509
P/OCF
-0.5914
P/CF
-0.5914
PEG
-0.0076
P/S
0.0000
EV Multiple
-0.7610
P/FV
-0.6483
DPS
0.0000
Latest Headlines (EST)
No Headlines Found
Revenue Product Segmentation
Year | Purchases | Sales | Total Bought | Total Sold |
---|
Transaction Date | Name | Type Of Owner | Price | Securities Owned | Securities Transacted | Security Name | Transaction Type |
---|
Less Than 3 Months
0.00 Shares Bought (0 %)
0.00 Shares Sold (0%)
3 - 6 Months
0.00 Shares Bought (0 %)
0.00 Shares Sold (0%)
6 - 9 Months
0.00 Shares Bought (0 %)
0.00 Shares Sold (0%)
9 - 12 Months
0.00 Shares Bought (0 %)
0.00 Shares Sold (0 %)
Investor Name | Investment Discretion | Type of Security | Shares Owned | Avg Price Paid | Market Value | Change In Market Value | Change In Market Value (%) | Ownership | Weight |
---|
Date | Investors Holding | Closed Positions | Increased Positions | Reduced Positions | New Positions | Total Invested | Put/Call Ratio | Total Calls | Total Puts |
---|
Owner | Shares Owned |
---|
2017 | 2018 | 2019 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|---|---|
Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Cost Of Revenue | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 5.03K | ▲ 5.70K | 5.70K |
Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | ▼ -5.03K | ▼ -5.70K | -5.70K |
Gross Profit Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Research And Development Expenses | 1.08M | ▼ 41.00 | ▲ 722.24K | ▼ 58.00 | ▲ 4.06M | ▼ 3.43M | ▼ 1.52M |
General And Administrative Expenses | 360.48K | ▼ 1.86K | ▲ 2.05K | ▼ 1.16K | ▲ 3.26K | ▲ 3.36K | ▼ 0.00 |
Selling And Marketing Expenses | 0.00 | 0.00 | ▲ 1.25M | ▼ 1.22M | ▲ 3.25M | ▲ 3.35M | ▼ 0.00 |
Selling General And Administrative Expenses | 360.48K | ▼ 1.86K | ▲ 1.25M | ▼ 1.22M | ▲ 3.26M | ▲ 3.36M | ▼ 2.73M |
Other Expenses | -2.88M | ▲ 0.00 | 0.00 | ▲ 1.21M | 1.21M | ▼ 0.00 | 0.00 |
Operating Expenses | -1.44M | ▲ 2.51K | ▲ 1.97M | ▼ 1.22M | ▲ 7.31M | ▼ 6.79M | ▼ 4.25M |
Cost And Expenses | 1.44M | ▼ 2.51K | ▲ 1.97M | ▼ 1.22M | ▲ 7.32M | ▼ 6.79M | ▼ 4.26M |
Interest Income | 0.00 | ▲ 562.00 | ▲ 4.16K | ▼ 145.00 | ▼ 0.00 | ▲ 92.00 | ▼ 0.00 |
Interest Expense | 222.60K | ▼ 0.00 | 0.00 | ▲ 145.37K | ▼ 1.00 | ▲ 91.69K | ▲ 145.02K |
Depreciation And Amortization | 0.00 | ▲ 1.90K | ▲ 1.97K | ▼ 1.22K | ▲ 5.03K | ▲ 5.70K | 5.70K |
Ebitda | -1.44M | ▲ -1.18K | ▼ -1.97M | ▲ -1.22M | ▼ -7.31M | ▲ -6.79M | ▲ -4.25M |
Ebitda Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating Income | -1.44M | ▲ -1.90K | ▼ -1.97M | ▲ -1.22M | ▼ -7.32M | ▲ -6.79M | ▲ -4.26M |
Operating Income Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Other Income Expenses Net | -222.60K | ▲ -1.18K | ▼ -61.28K | ▼ -411.54K | ▲ -24.87K | ▼ -1.06M | ▲ -301.71K |
Income Before Tax | -1.66M | ▲ -3.07K | ▼ -2.03M | ▲ -1.63M | ▼ -7.34M | ▼ -7.85M | ▲ -4.56M |
Income Before Tax Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income Tax Expense | 0.00 | ▼ -1.18K | ▼ -1.97K | ▲ 1.00 | 1.00 | ▼ -4.00 | -4.00 |
Net Income | -1.66M | ▲ -3.07K | ▼ -2.03M | ▲ -1.63M | ▼ -7.34M | ▼ -7.85M | ▲ -4.56M |
Net Income Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Eps | -0.16 | ▼ -0.48 | ▲ -0.18 | ▼ -0.34 | ▼ -0.50 | ▲ -0.29 | ▲ -0.14 |
Eps Diluted | -0.16 | ▼ -0.48 | ▲ -0.18 | ▼ -0.34 | ▼ -0.50 | ▲ -0.29 | ▲ -0.14 |
Weighted Average Shs Out | 10.60M | ▼ 6.36K | ▲ 11.14M | ▼ 4.82M | ▲ 14.75M | ▲ 26.68M | ▲ 32.43M |
Weighted Average Shs Out Dil | 10.60M | ▼ 6.36K | ▲ 11.14M | ▼ 4.82M | ▲ 14.75M | ▲ 26.68M | ▲ 32.43M |
Link | View | View | View | View | View | View | View |
Final Link | View | View | View | View | View | View | View |
2018 | 2019 | 2021 | 2022 | 2023 | 2024 | 1970 | |
---|---|---|---|---|---|---|---|
Cash And Cash Equivalents | 6.68K | ▲ 220.27K | ▼ 93.71K | ▲ 5.43M | ▲ 8.95M | ▼ 897.68K | ▼ |
Short Term Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Cash And Short Term Investments | 6.68K | ▲ 220.27K | ▼ 93.71K | ▲ 5.43M | ▲ 8.95M | ▼ 897.68K | ▼ |
Net Receivables | 0.00 | ▲ 75.39K | ▼ 61.21K | ▼ 38.55K | ▲ 41.24K | ▼ 10.66K | ▼ |
Inventory | 0.00 | 0.00 | ▼ -61.21K | ▲ -38.55K | ▼ -41.24K | ▲ 0.00 | |
Other Current Assets | 83.49K | ▲ 86.09K | ▲ 103.00K | ▲ 291.95K | ▲ 298.00K | ▲ 914.72K | ▼ |
Total Current Assets | 90.16K | ▲ 381.75K | ▼ 196.71K | ▲ 5.72M | ▲ 9.25M | ▼ 1.82M | ▼ |
Property Plant Equipment Net | 0.00 | 0.00 | 0.00 | ▲ 29.51K | ▼ 18.10K | ▼ 6.69K | ▼ |
Goodwill | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Intangible Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Goodwill And Intangible Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Long Term Investments | 0.00 | ▲ 54.47K | ▲ 67.95K | ▼ 0.00 | 0.00 | 0.00 | |
Tax Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Other Non Current Assets | 55.47K | ▲ 260.21K | ▲ 946.91K | ▼ 12.04K | ▲ 12.14K | ▲ 16.89K | ▼ |
Total Non Current Assets | 55.47K | ▲ 314.68K | ▲ 1.01M | ▼ 41.55K | ▼ 30.25K | ▼ 23.58K | ▼ |
Other Assets | 0.00 | 0.00 | ▲ 1.00 | 1.00 | ▼ 0.00 | 0.00 | |
Total Assets | 145.64K | ▲ 696.43K | ▲ 1.21M | ▲ 5.76M | ▲ 9.28M | ▼ 1.85M | ▼ |
Account Payables | 1.13M | ▲ 2.51M | ▲ 4.01M | ▼ 1.74M | ▲ 2.37M | ▲ 4.63M | ▼ |
Short Term Debt | 707.68K | ▼ 690.07K | ▲ 1.77M | ▼ -2.50B | ▲ 0.00 | ▲ 1.63M | ▼ |
Tax Payables | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Deferred Revenue | 0.00 | ▼ -1.00 | ▲ 2.50B | 2.50B | ▼ 0.00 | 0.00 | |
Other Current Liabilities | 576.31K | ▲ 835.68K | ▼ -2.50B | ▼ -2.50B | ▲ 986.44K | ▲ 1.65M | ▼ |
Total Current Liabilities | 2.41M | ▲ 4.04M | ▲ 7.20M | ▼ 2.40M | ▲ 3.36M | ▲ 7.92M | ▼ |
Long Term Debt | 6.39M | ▼ 152.06K | ▲ 313.48K | ▼ 0.00 | 0.00 | 0.00 | |
Deferred Revenue Non Current | 0.00 | ▲ 2.50M | 2.50M | 2.50M | 2.50M | 2.50M | ▼ |
Deferred Tax Liabilities Non Current | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Other Non Current Liabilities | 159.02K | ▲ 180.25K | ▼ 178.27K | ▲ 318.89K | ▼ 136.12K | ▲ 260.68K | ▼ |
Total Non Current Liabilities | 6.54M | ▼ 2.83M | ▲ 2.99M | ▼ 2.82M | ▼ 2.64M | ▲ 2.76M | ▼ |
Other Liabilities | 0.00 | ▲ 1.00 | ▼ 0.00 | 0.00 | ▲ 1.00 | 1.00 | ▼ |
Capital Lease Obligations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Total Liabilities | 8.96M | ▼ 6.87M | ▲ 10.20M | ▼ 5.22M | ▲ 6.00M | ▲ 10.68M | ▼ |
Preferred Stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Common Stock | 133.54K | ▲ 145.14K | 145.14K | ▲ 344.45K | ▲ 668.56K | ▲ 733.41K | ▼ |
Retained Earnings | -21.45M | ▼ -26.90M | ▼ -29.76M | ▼ -41.71M | ▼ -58.20M | ▼ -70.37M | ▼ |
Accumulated Other Comprehensive Income Loss | -11.25K | ▼ -18.70K | ▼ -19.38K | ▼ -151.74K | ▲ -50.79K | ▼ -158.07K | ▼ |
Other Total Stockholders Equity | 12.52M | ▲ 20.60M | ▲ 20.65M | ▲ 42.06M | ▲ 60.86M | ▲ 60.96M | ▼ |
Total Stockholders Equity | -8.81M | ▲ -6.17M | ▼ -8.98M | ▲ 542.39K | ▲ 3.28M | ▼ -8.83M | ▼ |
Total Equity | -8.81M | ▲ -6.17M | ▼ -8.98M | ▲ 542.39K | ▲ 3.28M | ▼ -8.83M | ▼ |
Total Liabilities And Stockholders Equity | 145.64K | ▲ 696.43K | ▲ 1.21M | ▲ 5.76M | ▲ 9.28M | ▼ 1.85M | ▼ |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Total Liabilities And Total Equity | 145.64K | ▲ 696.43K | ▲ 1.21M | ▲ 5.76M | ▲ 9.28M | ▼ 1.85M | ▼ |
Total Investments | 0.00 | ▲ 54.47K | ▲ 67.95K | ▼ 0.00 | 0.00 | 0.00 | |
Total Debt | 7.09M | ▼ 842.13K | ▲ 2.08M | ▼ 0.00 | 0.00 | ▲ 1.63M | ▼ |
Net Debt | 7.09M | ▼ 621.86K | ▲ 1.99M | ▼ -5.43M | ▼ -8.95M | ▲ 736.07K | ▼ |